Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
Telomir Pharmaceuticals, Inc. (TELO) had Return on Assets of -15.19% for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-0.71M |
|
-- |
|
-- |
|
$0.75M |
|
$-0.75M |
|
$0.04M |
|
$-0.71M |
|
$-0.71M |
|
$-0.71M |
|
$-0.71M |
|
$-0.71M |
|
$-0.71M |
|
$-0.75M |
|
$-0.75M |
|
68.78M |
|
68.78M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$4.64M |
|
-- |
|
-- |
|
$4.64M |
|
$0.24M |
|
-- |
|
-- |
|
$0.24M |
|
$4.40M |
|
$4.40M |
|
$4.40M |
|
68.78M |
|
| Cash Flow Statement Financials | |
$-3.37M |
|
-- |
|
$0.60M |
|
$7.29M |
|
$4.52M |
|
$-2.77M |
|
$0.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.60 |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.37M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.01% |
|
-16.01% |
|
|
Return on Assets |
-15.19% |
-16.01% |
|
$0.06 |
|
$-0.05 |
|
$-0.05 |
|